DNA Test Boosts Personalized Antidepressants
Scientists across Sweden, Denmark, and Germany are developing a groundbreaking DNA test designed to predict the most effective antidepressant for individuals, aiming to revolutionize mental health care by ending the frustrating trial-and-error method. This innovative genetic test, which analyzes a person's DNA using polygenic risk scores, promises to guide clinicians toward optimal drug selection for quicker symptom relief and improved patient outcomes, despite some existing cautions from the FDA regarding its routine use.